Cargando…

Getting to Zero Begins With Getting to Ten

The global “90-90-90” targets introduced by UNAIDS in 2014—90% of people living with HIV will know their HIV status; 90% of those will be on antiretroviral treatment; and 90% of those will achieve viral suppression by 2020—have become more than a useful heuristic device, and now are the predominant...

Descripción completa

Detalles Bibliográficos
Autor principal: Auerbach, Judith D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAIDS Journal of Acquired Immune Deficiency Syndromes 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820696/
https://www.ncbi.nlm.nih.gov/pubmed/31658195
http://dx.doi.org/10.1097/QAI.0000000000002167
_version_ 1783463997824040960
author Auerbach, Judith D.
author_facet Auerbach, Judith D.
author_sort Auerbach, Judith D.
collection PubMed
description The global “90-90-90” targets introduced by UNAIDS in 2014—90% of people living with HIV will know their HIV status; 90% of those will be on antiretroviral treatment; and 90% of those will achieve viral suppression by 2020—have become more than a useful heuristic device, and now are the predominant framework for monitoring progress in the HIV response. Although this allows for important reflection on where HIV treatment gaps and opportunities exist in any particular context and globally, it deflects attention away from other very important aspects of HIV epidemics and their often-disproportionate impact on specific populations. Most significantly, it begs the question, what about the other 10-10-10? APPROACH: This article takes a critical look at the 90-90-90 targets and what is known about the 10-10-10 left behind to highlight some core issues and attendant questions that should be prioritized if we really intend to “get to zero.” FINDINGS AND CONCLUSIONS: These issues include how the targets are measured in the first place, the limitations of focusing the global response only on antiretroviral treatment and only on people already living with HIV, and the need for more, basic social research to address the range of factors underlying disparities in who are and are not reached in the 90-90-90 framework.
format Online
Article
Text
id pubmed-6820696
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher JAIDS Journal of Acquired Immune Deficiency Syndromes
record_format MEDLINE/PubMed
spelling pubmed-68206962019-11-26 Getting to Zero Begins With Getting to Ten Auerbach, Judith D. J Acquir Immune Defic Syndr Supplement Article The global “90-90-90” targets introduced by UNAIDS in 2014—90% of people living with HIV will know their HIV status; 90% of those will be on antiretroviral treatment; and 90% of those will achieve viral suppression by 2020—have become more than a useful heuristic device, and now are the predominant framework for monitoring progress in the HIV response. Although this allows for important reflection on where HIV treatment gaps and opportunities exist in any particular context and globally, it deflects attention away from other very important aspects of HIV epidemics and their often-disproportionate impact on specific populations. Most significantly, it begs the question, what about the other 10-10-10? APPROACH: This article takes a critical look at the 90-90-90 targets and what is known about the 10-10-10 left behind to highlight some core issues and attendant questions that should be prioritized if we really intend to “get to zero.” FINDINGS AND CONCLUSIONS: These issues include how the targets are measured in the first place, the limitations of focusing the global response only on antiretroviral treatment and only on people already living with HIV, and the need for more, basic social research to address the range of factors underlying disparities in who are and are not reached in the 90-90-90 framework. JAIDS Journal of Acquired Immune Deficiency Syndromes 2019-12-01 2019-10-29 /pmc/articles/PMC6820696/ /pubmed/31658195 http://dx.doi.org/10.1097/QAI.0000000000002167 Text en Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Supplement Article
Auerbach, Judith D.
Getting to Zero Begins With Getting to Ten
title Getting to Zero Begins With Getting to Ten
title_full Getting to Zero Begins With Getting to Ten
title_fullStr Getting to Zero Begins With Getting to Ten
title_full_unstemmed Getting to Zero Begins With Getting to Ten
title_short Getting to Zero Begins With Getting to Ten
title_sort getting to zero begins with getting to ten
topic Supplement Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820696/
https://www.ncbi.nlm.nih.gov/pubmed/31658195
http://dx.doi.org/10.1097/QAI.0000000000002167
work_keys_str_mv AT auerbachjudithd gettingtozerobeginswithgettingtoten